Pulmonary arterial hypertension, or PAH, is a rare and severe disease characterized by elevated blood pressure in the ...

Please provide your email address to receive an email when new articles are posted on . Hospitalizations for pulmonary hypertension have increased from 1980 to 2002, resulting in 200,000 ...

The Natural Medicines Comprehensive Database [3] has five potential categories of efficacy: effective, likely effective, possibly effective, possibly ineffective, or likely ineffective. The database ...

Pulmonary arterial hypertension (PAH) is a type of high blood pressure in the arteries in your lungs. It happens when these arteries become narrow or blocked, making it harder for blood to flow ...

The World Health Organization symposium offers a new treatment-oriented classification of pulmonary hypertension based on an improved understanding of its pathophysiology. Regardless of the etiology, ...

Pulmonary arterial hypertension is characterized by pulmonary vascular remodeling, cellular proliferation, and poor long-term outcomes. Dysfunctional bone morphogenetic protein pathway signaling is ...

Panelists discuss how the pathophysiology of pulmonary arterial hypertension involves complex mechanisms across multiple genetic and treatment pathways, with over 20 identified genes and four major ...

This review focuses on recent studies relevant to the management of hypertension in patients with COPD. Contemporary evidence concerning the effects of antihypertensive-drug classes on COPD ...